A detailed history of Family Legacy, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Family Legacy, Inc. holds 8,630 shares of ABT stock, worth $1.03 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
8,630
Previous 8,630 -0.0%
Holding current value
$1.03 Million
Previous $896,000 9.71%
% of portfolio
0.33%
Previous 0.32%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$100.73 - $112.44 $1,007 - $1,124
-10 Reduced 0.12%
8,630 $896,000
Q1 2024

Apr 24, 2024

SELL
$109.52 - $120.96 $16,975 - $18,748
-155 Reduced 1.76%
8,640 $982,000
Q2 2023

Aug 04, 2023

SELL
$100.78 - $112.29 $1,007 - $1,122
-10 Reduced 0.11%
8,795 $958,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $38,744 - $45,604
400 Added 4.76%
8,805 $891,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $44,297 - $51,968
-466 Reduced 5.25%
8,405 $922,000
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $1,531 - $1,850
-15 Reduced 0.17%
8,871 $961,000
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $2,850 - $3,476
-25 Reduced 0.28%
8,886 $1.05 Million
Q4 2021

Jan 18, 2022

BUY
$115.53 - $141.46 $86,647 - $106,095
750 Added 9.19%
8,911 $1.21 Million
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $2,644 - $3,113
-25 Reduced 0.31%
8,161 $965,000
Q1 2021

Apr 09, 2021

BUY
$108.84 - $128.23 $11,645 - $13,720
107 Added 1.32%
8,186 $981,000
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $4,725 - $5,148
-45 Reduced 0.55%
8,079 $885,000
Q3 2020

Oct 09, 2020

BUY
$91.64 - $111.29 $1,191 - $1,446
13 Added 0.16%
8,124 $884,000
Q2 2020

Jul 20, 2020

BUY
$76.57 - $98.0 $5,283 - $6,762
69 Added 0.86%
8,111 $742,000
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $12,564 - $18,372
-200 Reduced 2.43%
8,042 $635,000
Q4 2019

Jan 14, 2020

SELL
$78.51 - $87.4 $1,962 - $2,185
-25 Reduced 0.3%
8,242 $711,000
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $289,713 - $314,139
3,540 Added 74.89%
8,267 $689,000
Q2 2019

Jul 25, 2019

SELL
$72.88 - $85.0 $3,571 - $4,165
-49 Reduced 1.03%
4,727 $398,000
Q1 2019

May 06, 2019

SELL
$66.22 - $80.06 $1,324 - $1,601
-20 Reduced 0.42%
4,776 $375,000
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $2,294 - $2,599
-35 Reduced 0.72%
4,796 $347,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $2,797 - $3,374
46 Added 0.96%
4,831 $354,000
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $4,087 - $4,511
-71 Reduced 1.46%
4,785 $292,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $4,782 - $5,407
85 Added 1.78%
4,856 $291,000
Q4 2017

Feb 01, 2018

BUY
$53.68 - $57.47 $256,107 - $274,189
4,771
4,771 $272,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Family Legacy, Inc. Portfolio

Follow Family Legacy, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Legacy, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Legacy, Inc. with notifications on news.